Composition for the control of wound scar production
US5902609A · kind A · utility
6Cited by
4References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 25, 1996 |
| Grant date | May 11, 1999 |
| Priority date | — |
| Expiry date | Oct 25, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to a composition for controlling wound scar production containing a calcium antagonist and a protein synthesis inhibitor. The method can be used to minimize wound scars, such as hypertrophic wound healing disorders keloids and burn scar contractures in humans or other mammals, particularly those individually prone to excesssive scarring Calcium antagonist treatment can also be used to control diseases associated with excessive scarring. such as cirrhosis of the liver, constructive pericarditis Dupuytren's disease of the hand, plantar fibrosis of the foot, and various other fibromatoses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.